217 related articles for article (PubMed ID: 23596076)
1. White matter microstructure deteriorates across cognitive stages in Parkinson disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Neurology; 2013 May; 80(20):1841-9. PubMed ID: 23596076
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study.
Teipel SJ; Meindl T; Wagner M; Stieltjes B; Reuter S; Hauenstein KH; Filippi M; Ernemann U; Reiser MF; Hampel H
J Alzheimers Dis; 2010; 22(2):507-22. PubMed ID: 20847446
[TBL] [Abstract][Full Text] [Related]
3. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study.
Zhuang L; Wen W; Zhu W; Trollor J; Kochan N; Crawford J; Reppermund S; Brodaty H; Sachdev P
Neuroimage; 2010 Oct; 53(1):16-25. PubMed ID: 20595067
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
[TBL] [Abstract][Full Text] [Related]
5. Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment.
Chua TC; Wen W; Chen X; Kochan N; Slavin MJ; Trollor JN; Brodaty H; Sachdev PS
Am J Geriatr Psychiatry; 2009 Jul; 17(7):602-13. PubMed ID: 19546655
[TBL] [Abstract][Full Text] [Related]
6. White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study.
Kraus MF; Susmaras T; Caughlin BP; Walker CJ; Sweeney JA; Little DM
Brain; 2007 Oct; 130(Pt 10):2508-19. PubMed ID: 17872928
[TBL] [Abstract][Full Text] [Related]
7. White matter microstructural integrity and cognitive function in a general elderly population.
Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
9. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
[TBL] [Abstract][Full Text] [Related]
10. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
[TBL] [Abstract][Full Text] [Related]
11. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
[TBL] [Abstract][Full Text] [Related]
12. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
[TBL] [Abstract][Full Text] [Related]
13. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions.
Hulst HE; Steenwijk MD; Versteeg A; Pouwels PJ; Vrenken H; Uitdehaag BM; Polman CH; Geurts JJ; Barkhof F
Neurology; 2013 Mar; 80(11):1025-32. PubMed ID: 23468546
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis.
Kamagata K; Motoi Y; Tomiyama H; Abe O; Ito K; Shimoji K; Suzuki M; Hori M; Nakanishi A; Sano T; Kuwatsuru R; Sasai K; Aoki S; Hattori N
Eur Radiol; 2013 Jul; 23(7):1946-55. PubMed ID: 23404139
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
17. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.
Ibarretxe-Bilbao N; Junque C; Marti MJ; Valldeoriola F; Vendrell P; Bargallo N; Zarei M; Tolosa E
Mov Disord; 2010 Sep; 25(12):1888-94. PubMed ID: 20669268
[TBL] [Abstract][Full Text] [Related]
18. Characterizing mild cognitive impairment in Parkinson's disease.
Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
[TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity.
Wang HC; Hsu JL; Leemans A
Arch Neurol; 2012 Oct; 69(10):1340-8. PubMed ID: 22825428
[TBL] [Abstract][Full Text] [Related]
20. White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
Bledsoe IO; Stebbins GT; Merkitch D; Goldman JG
Neurology; 2018 Dec; 91(24):e2244-e2255. PubMed ID: 30429273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
